Bloomage Biotechnology Corporation Limited — Investor Relations & Filings
About Bloomage Biotechnology Corporation Limited
Bloomage Biotechnology Corporation Limited is a global leader in the research, development, and production of hyaluronic acid and other bioactive substances. Utilizing advanced microbial fermentation and cross-linking technologies, the company provides high-quality raw materials for the pharmaceutical, cosmetic, and food sectors. Its product portfolio includes pharmaceutical-grade sodium hyaluronate, medical devices for ophthalmology and orthopedics, and aesthetic medicine solutions such as dermal fillers. Additionally, Bloomage develops and markets functional skin care brands and health foods. As the world's largest manufacturer of hyaluronic acid, the company maintains a vertically integrated industrial chain, focusing on biotechnology innovation to enhance human health and beauty. Its operations span global markets, serving diverse sectors with high-purity bioactive ingredients and finished consumer products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 华熙生物关于续聘会计师事务所的公告 | 2025-09-30 | Chinese | |
| 北京市通商律师事务所关于华熙生物科技股份有限公司控股股东增持公司股份的法律意见书 | 2025-09-30 | Chinese | |
| 华熙生物关于控股股东增持计划实施完毕暨增持股份结果公告 | 2025-09-30 | Chinese | |
| 华熙生物关于控股股东增持股份进展暨权益变动触及5%整数倍的提示性公告 | 2025-09-23 | Chinese | |
| 华熙生物简式权益变动报告书 | 2025-09-23 | Chinese | |
| 华熙生物关于召开2025年半年度业绩说明会的公告 | 2025-09-17 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39082960 | 华熙生物关于续聘会计师事务所的公告 | 2025-09-30 | Chinese | ||
| 39082950 | 北京市通商律师事务所关于华熙生物科技股份有限公司控股股东增持公司股份的法律意见书 | 2025-09-30 | Chinese | ||
| 39082941 | 华熙生物关于控股股东增持计划实施完毕暨增持股份结果公告 | 2025-09-30 | Chinese | ||
| 39082934 | 华熙生物关于控股股东增持股份进展暨权益变动触及5%整数倍的提示性公告 | 2025-09-23 | Chinese | ||
| 39082929 | 华熙生物简式权益变动报告书 | 2025-09-23 | Chinese | ||
| 39082922 | 华熙生物关于召开2025年半年度业绩说明会的公告 | 2025-09-17 | Chinese | ||
| 39082916 | 华熙生物关于控股股东增持股份进展暨增持金额超过区间下限的公告 | 2025-09-07 | Chinese | ||
| 39082907 | 华熙生物关于控股股东增持股份进展暨增持金额过半的公告 | 2025-08-29 | Chinese | ||
| 39082905 | 华熙生物关于控股股东首次增持公司股份暨增持计划进展的公告 | 2025-08-28 | Chinese | ||
| 39082898 | 华熙生物2025年半年度报告摘要 | 2025-08-26 | Chinese | ||
| 39082893 | 华熙生物关于2025年第二季度计提大额资产减值准备的公告 | 2025-08-26 | Chinese | ||
| 39082886 | 华熙生物2025年度“提质增效重回报”专项行动方案的半年度评估报告 | 2025-08-26 | Chinese | ||
| 39082884 | 华熙生物2025年半年度报告 | 2025-08-26 | Chinese | ||
| 39082883 | 华熙生物关于控股股东取得增持股份专项贷款承诺函的公告 | 2025-08-13 | Chinese | ||
| 39082877 | 华熙生物关于发酵法软骨素钠完成医疗器械主文档登记的自愿性披露公告 | 2025-08-11 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Bloomage Biotechnology Corporation Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58370/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58370 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58370 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58370 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58370}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bloomage Biotechnology Corporation Limited (id: 58370)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.